Substitution of glutamine for arginine 1131. A newly identified mutation in the catalytic loop of the tyrosine kinase domain of the human insulin receptor.

作者: M. Kishimoto , M. Hashiramoto , K. Yonezawa , K. Shii , T. Kazumi

DOI: 10.1016/S0021-9258(19)78131-9

关键词:

摘要: We studied a patient with severe insulin resistance and remarkable decrease in the vivo autophosphorylation of receptor. Using polymerase chain reaction-single strand conformation polymorphism method direct sequencing, we identified heterozygous mutation substituting Gln for Arg1131 putative "catalytic loop" tyrosine kinase domain receptor gene. The Gln1131 mutant was expressed by transfection Chinese hamster ovary cells compared expressing wild-type Both receptors were on cell surface displayed similar insulin-binding affinity. impaired activity inhibited ability to phosphorylate endogenous substrate substrate-I. In addition, exhibited diminished tyrosine-phosphorylated phosphatidylinositol 3-kinase myelin basic protein activities cells. It also demonstrated defective mediation signal stimulating 2-deoxy-D-glucose transport thymidine incorporation, endocytosis, insulin-induced down-regulation. Unlike previously described catalytic loop that substituted Glu Ala1135, retained proteolytic cleavage proreceptor into separate subunits. Our results demonstrate naturally occurring (R1131Q) impairment function our patient. indicate is important receptor-mediated action suggest amino acids constituting kinases may possess different modes order retain function.

参考文章(48)
D A McClain, H Maegawa, J Lee, T J Dull, A Ulrich, J M Olefsky, A mutant insulin receptor with defective tyrosine kinase displays no biologic activity and does not undergo endocytosis. Journal of Biological Chemistry. ,vol. 262, pp. 14663- 14671 ,(1987) , 10.1016/S0021-9258(18)47847-7
M Hashiramoto, T Kadowaki, A.E. Clark, A Muraoka, K Momomura, H Sakura, K Tobe, Y Akanuma, Y Yazaki, G.D. Holman, Site-directed mutagenesis of GLUT1 in helix 7 residue 282 results in perturbation of exofacial ligand binding. Journal of Biological Chemistry. ,vol. 267, pp. 17502- 17507 ,(1992) , 10.1016/S0021-9258(19)37070-X
H Kadowaki, T Kadowaki, A Cama, B Marcus-Samuels, A Rovira, C L Bevins, S I Taylor, Mutagenesis of lysine 460 in the human insulin receptor. Effects upon receptor recycling and cooperative interactions among binding sites. Journal of Biological Chemistry. ,vol. 265, pp. 21285- 21296 ,(1990) , 10.1016/S0021-9258(17)45358-0
M Kasuga, J A Hedo, K M Yamada, C R Kahn, The structure of insulin receptor and its subunits. Evidence for multiple nonreduced forms and a 210,000 possible proreceptor. Journal of Biological Chemistry. ,vol. 257, pp. 10392- 10399 ,(1982) , 10.1016/S0021-9258(18)34032-8
D S Russell, R Gherzi, E L Johnson, C K Chou, O M Rosen, The protein-tyrosine kinase activity of the insulin receptor is necessary for insulin-mediated receptor down-regulation. Journal of Biological Chemistry. ,vol. 262, pp. 11833- 11840 ,(1987) , 10.1016/S0021-9258(18)60889-0
A Ando, K Momomura, K Tobe, R Yamamoto-Honda, H Sakura, Y Tamori, Y Kaburagi, O Koshio, Y Akanuma, Y Yazaki, Enhanced insulin-induced mitogenesis and mitogen-activated protein kinase activities in mutant insulin receptors with substitution of two COOH-terminal tyrosine autophosphorylation sites by phenylalanine Journal of Biological Chemistry. ,vol. 267, pp. 12788- 12796 ,(1992) , 10.1016/S0021-9258(18)42345-9